News & Events
Patent status of MS disease-modifying therapies (DMTs) around the world
Collaborating with the Medicines Patent Pool as MSIF continues work on improving access to MS treatments
Tawasol – March 2022 issue
Your update from MS organisations in the Arab Region
Could a blood test measuring Neurofilament light chain levels predict future MS activity?
A study funded by the International Progressive MS Alliance shows a blood test may have potential in…
Making information on caregiving more accessible
Adapting the MS Society of India’s ‘Guide for MS Caregivers’ for a global audience.
What treatments are approved for children and young people with MS?
We look into these in more detail to understand how the treatment decisions are made by regulators.
MS Brain Health Awards 2022 go live!
Find out more about your chance to enter the first ever MS Brain Health Awards
New MS organisations join The May 50K
Esclerosis Múltiple Argentina and the MS Society of Canada sign up to the challenge
Researchers strengthen the link between Epstein-Barr Virus (EBV) and the risk of developing MS
Does EBV cause MS?
Uruguay’s MS Compass
Esclerosis Múltiple Uruguay creates a digital tool to help people understand and live better with MS.
Fixing an imperfect system through the voices of those with lived experience
Find out more about the Global PROMS Initiative - Patient Reported Outcomes for MS
Mesenchymal stem cell therapy for MS – results of international trial
Global trial of mesenchymal stem cell therapy showed no reduction in inflammation for people with active MS
Let’s talk about myelin
To stop MS, we need treatments that repair damage to the protective myelin coating around nerves.